Broad potent neutralising antibodies from an African donor reveal a new HIV-1 vaccine target Science 326 (5950), 285-289, 2009 | 2105 | 2009 |
Broad neutralisation coverage of HIV by multiple highly potent antibodies Nature 477 (7365), 466-470, 2011 | 1741 | 2011 |
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay … MD Simek, W Rida, FH Priddy, P Pung, E Carrow, DS Laufer, JK Lehrman, ... Journal of virology 83 (14), 7337-7348, 2009 | 681 | 2009 |
Infection with Trichomonas vaginalis Increases the Risk of HIV-1 Acquisition RS McClelland, L Sangaré, WM Hassan, L Lavreys, K Mandaliya, J Kiarie, ... The Journal of infectious diseases 195 (5), 698-702, 2007 | 656 | 2007 |
HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads JM Baeten, B Chohan, L Lavreys, V Chohan, RS McClelland, L Certain, ... The Journal of infectious diseases 195 (8), 1177-1180, 2007 | 355 | 2007 |
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract A Rebbapragada, C Wachihi, C Pettengell, S Sunderji, S Huibner, ... Aids 21 (5), 589-598, 2007 | 250 | 2007 |
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression A Piantadosi, D Panteleeff, CA Blish, JM Baeten, W Jaoko, RS McClelland, ... Journal of virology 83 (19), 10269-10274, 2009 | 233 | 2009 |
Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case … RS McClelland, JR Lingappa, S Srinivasan, J Kinuthia, GC John-Stewart, ... The Lancet infectious diseases 18 (5), 554-564, 2018 | 226 | 2018 |
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa E Karita, N Ketter, MA Price, K Kayitenkore, P Kaleebu, A Nanvubya, ... PloS one 4 (2), e4401, 2009 | 207 | 2009 |
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women JM Baeten, S Benki, V Chohan, L Lavreys, RS McClelland, K Mandaliya, ... Aids 21 (13), 1771-1777, 2007 | 207 | 2007 |
Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection RT Lester, XD Yao, TB Ball, LR McKinnon, R Kaul, C Wachihi, W Jaoko, ... Aids 22 (6), 685-694, 2008 | 186 | 2008 |
Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding SM Graham, SE Holte, NM Peshu, BA Richardson, DD Panteleeff, ... Aids 21 (4), 501-507, 2007 | 183 | 2007 |
Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis RS McClelland, BA Richardson, WM Hassan, SM Graham, J Kiarie, ... The Journal of infectious diseases 199 (12), 1883-1890, 2009 | 174 | 2009 |
HIV-Exposed Seronegative Commercial Sex Workers Show a Quiescent Phenotype in the CD4+ T Cell Compartment and Reduced Expression of HIV-Dependent … PJ McLaren, T Blake Ball, C Wachihi, W Jaoko, DJ Kelvin, A Danesh, ... The Journal of infectious diseases 202 (Supplement_3), S339-S344, 2010 | 149 | 2010 |
Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study VBSG Jespers V, Crucitti T, Menten J, Verhelst R, Mwaura M, Mandaliya K ... Plos One 9 (10), e109670, 2014 | 141 | 2014 |
Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition SM Iqbal, TB Ball, P Levinson, L Maranan, W Jaoko, C Wachihi, BJ Pak, ... Aids 23 (13), 1669-1677, 2009 | 139 | 2009 |
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and … BS Peters, W Jaoko, E Vardas, G Panayotakopoulos, P Fast, C Schmidt, ... Vaccine 25 (11), 2120-2127, 2007 | 125 | 2007 |
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial RS McClelland, BA Richardson, WM Hassan, V Chohan, L Lavreys, ... The Journal of infectious diseases 197 (10), 1361-1368, 2008 | 116 | 2008 |
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa W Jaoko, E Karita, K Kayitenkore, G Omosa-Manyonyi, S Allen, S Than, ... PloS one 5 (9), e12873, 2010 | 114 | 2010 |
Validity of the vaginal discharge algorithm among pregnant and non-pregnant women in Nairobi, Kenya K Fonck, N Kidula, W Jaoko, B Estambale, P Claeys, J Ndinya-Achola, ... Sexually transmitted infections 76 (1), 33-38, 2000 | 108 | 2000 |